Medicare Enrolled

Dr. Sean Castellucci, D.O.

Urology Physician · Bradenton, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
200 3RD AVE W, Bradenton, FL 34205
9417920340
In practice since 2007 (18 years)
NPI: 1487869400 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Castellucci from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Castellucci? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Castellucci

Dr. Sean Castellucci is an urology physician in Bradenton, FL, with 18 years in practice. Based on federal Medicare data, Dr. Castellucci performed 43,292 Medicare services across 2,692 unique beneficiaries.

Between the years covered by Open Payments, Dr. Castellucci received a total of $12,149 from 55 pharmaceutical and/or device companies across 332 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Castellucci is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice▲ Top 2% volume in FL$ $12,149 industry payments

Medicare Practice Summary

Medicare Utilization ↗
43,292
Medicare services
Top 2% in FL for urology physician
2,692
Unique beneficiaries
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~2,405 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Testosterone undecanoate injection (Aveed)36,000$1$6
Denosumab injection (Prolia/Xgeva)2,221$18$45
BCG treatment for bladder cancer1,601$2$9
Office visit, established patient (30-39 min)679$89$320
Automated urinalysis444$2$10
Bladder ultrasound after voiding327$8$60
Office visit, established patient (20-29 min)218$62$216
Electronic assessment of bladder emptying212$8$132
New patient office visit (45-59 min)150$116$501
Diagnostic exam of bladder and urethra using an endoscope136$60$417
Injection, triptorelin pamoate, 3.75 mg112$289$991
Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings109$25$635
Complex measurement of pressure of urine flow in bladder with voiding pressure studies108$277$936
Insertion of device into abdomen with pressure and urine flow rate study108$146$415
Leuprolide acetate (for depot suspension), 7.5 mg105$132$685
Biopsy of bladder using an endoscope97$96$467
Office visit, established patient (10-19 min)60$42$129
Drug injection, under skin or into muscle53$10$71
Insertion of sacral nerve neurostimulator electrode array52$286$1,313
Imaging of urinary tract following injection of a contrast agent48$19$71
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle45$23$107
Biopsy of prostate gland42$100$458
Ultrasound scan of pelvic region through rectum42$25$134
Instillation of anti-cancer drug into bladder37$66$363
Insertion of stent in ureter using an endoscope35$104$594
Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional33$17$61
Simple insertion of temporary bladder tube31$41$238
Insertion of peripheral or gastric neurostimulator generator31$68$535
Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope30$578$2,756
Office visit, established patient, complex (40-54 min)29$135$431
Injection procedure to cause erection20$71$292
Complete ultrasound of penis artery and vein blood flow20$88$542
Destruction and/or removal of growth of bladder and urethra using an endoscope, 2.0-5.0 cm15$213$956
Crushing of stone of ureter with insertion of stent using an endoscope15$316$1,336
Electronic analysis of implanted neurostimulator generator with complex spinal cord or peripheral nerve stimulator programming14$33$248
New patient office visit (30-44 min)13$54$325
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.1% high complexity
90.1% medium
9.7% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$12,149
Total received (2018-2024)
Avg $1,736/year across 7 years
Top 18% in FL for urology physician
55
Companies
332
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,553 (95.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$595 (4.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,020
2023
$1,326
2022
$3,126
2021
$1,728
2020
$1,339
2019
$1,859
2018
$1,751

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Axonics, Inc.
$4,114
KARL STORZ Endoscopy-America
$1,459
Medtronic USA, Inc.
$1,160
Astellas Pharma US Inc
$835
Rochester Medical Corporation
$792
Boston Scientific Corporation
$491
Endo Pharmaceuticals Inc.
$310
Janssen Biotech, Inc.
$275
NeoTract Inc.
$211
Wilmington Medical Supply, Inc.
$165
Teleflex LLC
$162
Biocompatibles, Inc.
$148
Novartis Pharmaceuticals Corporation
$144
PFIZER INC.
$140
Axonics Modulation Technologies, Inc.
$96
Blue Earth Diagnostics Limited
$96
Sumitomo Pharma America, Inc.
$95
Olympus America Inc.
$91
BOSTON SCIENTIFIC CORPORATION
$84
Medtronic, Inc.
$71
Tolmar, Inc.
$69
Avadel Specialty Pharmaceuticals, LLC
$66
IntrinsiQ Specialty Solutions, Inc.
$66
Coloplast Corp
$62
Laborie Medical Technologies Corp.
$60
UROVANT SCIENCES INC
$59
Ferring Pharmaceuticals Inc.
$59
UROGEN PHARMA, INC.
$58
Bayer Healthcare Pharmaceuticals Inc.
$52
COLOPLAST CORP
$46
PROCEPT BioRobotics Corporation
$45
Baxter Healthcare
$45
180 Medical, Inc.
$40
CIVCO Medical Instruments
$40
MEDIVATION FIELD SOLUTIONS LLC
$37
Egalet US Inc
$36
ROCHESTER MEDICAL CORPORATION
$33
Antares Pharma, Inc.
$31
TOLMAR Pharmaceuticals, Inc.
$28
Myriad Genetic Laboratories, Inc.
$28
Janssen Scientific Affairs, LLC
$28
Rigicon,Inc.
$24
UroGen Pharma, Inc.
$18
Supernus Pharmaceuticals, Inc.
$17
Bayer HealthCare Pharmaceuticals Inc.
$17
Endo USA, Inc.
$16
IMMUNITYBIO, INC.
$16
Myovant Sciences Inc.
$16
PRN Medical Services, LLC
$15
Retrophin, Inc.
$15
Verity Pharmaceuticals Inc.
$15
BIOPROTECT MEDICAL, INC.
$15
AngioDynamics, Inc.
$13
Dendreon Pharmaceuticals LLC
$13
Allergan Inc.
$11
Top 3 companies account for 55.4% of total payments
Associated products mentioned in payments ›
(815) Thiola · 24/26 FR. · 24FR BIPLR COAG ELECTRDE · AFINITOR · AMBICOR · AMS · ANKTIVA · AQUABEAM ROBOTIC SYSTEM · AVEED · Altis · Axonics · Axonics r-SNM System · Axumin · BIOPROTECT BALLOON IMPLANT SYSTEM · BIPOLAR · BOTOX THERAPEUTIC · BRACAnalysis CDx · Bulkamid · C-VIEW · CCU/LIGHT SOURCE/MONITOR · CUTTING LOOP · EDEX · ELIGARD · ERLEADA · Erleada · FIRMAGON · FLEXIBLE VIDEO URETHRO-CYSTOSCOPE · Flex-X · GEMTESA · GENERAL BPH · GENERAL FEMALE SUI · GENERAL KIDNEY STONE DISEASE · GENTLECATH · GREENLIGHT · IMAGE1 S CONNECT · IMAGE1 X-LINK · INTERSTIM · JELMYTO · MYRBETRIQ · Myrbetriq · NANOKNIFE · Noctiva · Nubeqa · ORGOVYX · Optilume BPH Drug Coated Balloon Catheter · PKG/6 · PLUVICTO · POSLUMA · PROVENGE · Prolaris · RED RUBBER · ROCHESTER MAGIC3 · Rigi10 Malleable Penile Prosthesis · SELF-CATH · SPECTRA · SPEEDICATH · SPRIX · STERILE · SUTENT · SpaceOAR VUE System - 10mL · TELE PACK X LED · TISSEEL · TITAN · TOVIAZ · Titan · Trelstar · UROLIFT · UroLift · VISUAL-ICE · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · ZYTIGA · iTIND System · n.a. · rezum Generator
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (95%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $28 per 100 Medicare services performed
Looking for a urology physician in Bradenton?
Compare urology physicians in the Bradenton area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology Physicians within 10 mi
54
Per 100K population
13.0
County median income
$75,792
Nearest hospital
SUNCOAST BEHAVIORAL HEALTH CENTER
4.2 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Castellucci is a mixed practice specialist, with above-average Medicare volume (top 2% in FL), and high industry engagement (low-engagement, top 18%), with 18 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Castellucci experienced with testosterone undecanoate injection (aveed)?
Based on Medicare claims data, Dr. Castellucci performed 36,000 testosterone undecanoate injection (aveed) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Castellucci receive payments from pharmaceutical companies?
Yes. Dr. Castellucci received a total of $12,149 from 55 companies across 332 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Castellucci's costs compare to other urology physicians in Bradenton?
Dr. Castellucci's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Castellucci) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →